Recombinant ITGA2 (Vatelizumab Biosimilar) antibody

Catalog No. ABIN7598085

This Humanized Chimeric antibody specifically detects ITGA2 (Vatelizumab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant ITGA2 (Vatelizumab Biosimilar) antibody (ABIN7598085)

Target: ITGA2 (Vatelizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This ITGA2 (Vatelizumab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-ITGA2 (Vatelizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Vatelizumab Biosimilar Antibody

Specificity: Collagen receptor, ITGA2, VLA-2 subunit alpha, CD49B, CD49 antigen-like family member B, Platelet membrane glycoprotein Ia, GPIa, Integrin alpha-2, CD49b

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for ITGA2 (Vatelizumab Biosimilar)

Target: ITGA2 (Vatelizumab Biosimilar)

Alternative Name: Vatelizumab Biosimilar

Target Type: Biosimilar

Background: Collagen receptor, ITGA2, VLA-2 subunit alpha, CD49B, CD49 antigen-like family member B, Platelet membrane glycoprotein Ia, GPIa, Integrin alpha-2, CD49b

UniProt: P17301

CAS-No: 1238217-55-4